APLS Apellis Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases

Industry Biotechnology

Get AI intraday signals

APLS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For APLS
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

APLS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For APLS
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

APLS is expected to report earnings to fall 4.73% to -28 cents per share on November 04

Apellis Pharmaceuticals APLS Stock Earnings Reports

Q3'24

Est.

$-0.29

Q2'24

Beat

by $0.01

Q1'24

Missed

by $0.07

Q4'23

Est.

$-0.73

Q3'23

Missed

by $0.18

The last earnings report on August 01 showed earnings per share of -30 cents, beating the estimate of -30 cents. With 2.45M shares outstanding, the current market capitalization sits at 3.51B.

A.I. Advisor

published General Information

General Information

a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Medical Distributors

Address

100 Fifth Avenue

Phone

+1 617 977-5700

Employees

706

Web

https://www.apellis.com

Interesting Tickers

CRYPTO / NAME	Price $	Chg $	Chg %
		1 Day
BTC.X	63193.023000	747.933600	+1.20%
Bitcoin cryptocurrency
SPY	579.58	3.45	+0.60%
SPDR® S&P 500® ETF Trust
GME	20.83	-0.08	-0.38%
GameStop Corp
AAPL	227.55	-1.49	-0.65%
Apple
TSLA	217.80	-20.97	-8.78%
Tesla

APLS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with IMVT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then IMVT could also see price increases.

Ticker / NAME	Correlation To APLS	1D Price Change %
APLS	100%	+1.76%
IMVT - APLS	39% Loosely correlated	+1.57%
PGEN - APLS	37% Loosely correlated	+7.68%
ZYME - APLS	36% Loosely correlated	+2.80%
FOLD - APLS	36% Loosely correlated	+4.48%
BCRX - APLS	35% Loosely correlated	+4.35%
More